Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Autism Research : Official Journal of the International Society for Autism Research|September 5, 2024
Autistic-relevant behavioral phenotypes of a mouse model of cyclin-dependent kinase-like 5 deficiency disorderNicola Mottolese, Oceane Coiffard, Celeste Ferraguto, et al.Journal of Neuroinflammation|July 9, 2021
Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorderGiuseppe Galvani, Nicola Mottolese, Laura Gennaccaro, et al.Journal of Neurodevelopmental Disorders|November 26, 2024
Effects of a ciliary neurotrophic factor (CNTF) small-molecule peptide mimetic in an in vitro and in vivo model of CDKL5 deficiency disorderNicola Mottolese, Manuela Loi, Stefania Trazzi, et al.Biomolecules|September 28, 2023
Voluntary Running Improves Behavioral and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency DisorderNicola Mottolese, Beatrice Uguagliati, Marianna Tassinari, et al.International Journal of Molecular Sciences|July 29, 2025
Adult-Onset Deletion of CDKL5 in Forebrain Glutamatergic Neurons Impairs Synaptic Integrity and Behavior in MiceNicola Mottolese, Feliciana Iannibelli, Giulia Candini, et al.International Journal of Molecular Sciences|August 12, 2022
Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency DisorderMarianna Tassinari, Nicola Mottolese, Giuseppe Galvani, et al.Neurobiology of Disease|May 10, 2023
Early-onset brain alterations during postnatal development in a mouse model of CDKL5 deficiency disorderMarianna Tassinari, Beatrice Uguagliati, Stefania Trazzi, et al.International Journal of Molecular Sciences|June 2, 2021
Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of <i>CDKL5</i> Deficiency DisorderManuela Loi, Laura Gennaccaro, Claudia Fuchs, et al.International Journal of Molecular Sciences|March 28, 2026
Endocannabinoid Enhancement via MAGL Inhibition in CDKL5 Deficiency: Selective Cellular Benefits and Domain-Specific Functional Effects in Adult <i>Cdkl5</i> KO MiceManuela Loi, Nicola Mottolese, Giorgio Medici, et al.Frontiers in Bioengineering and Biotechnology|February 6, 2026
A cross-correction gene therapy approach for CDKL5 deficiency disorder improves the pathological phenotype of CDD patient-derived cortical organoidsGiorgio Medici, Angelica M Bove, Stefania Trazzi, et al.Pageof 2